Diseases treated by stem cells
Acute Leukemias Acute Biphenotypic Leukemia Acute Lymphocytic Leukemia (ALL) Acute Myelogenous Leukemia (AML) Acute Undifferentiated Leukemia
Chronic Leukemias Chronic Lymphocytic Leukemia (CLL) Chronic Myelogenous Leukemia (CML) Juvenile Chronic Myelogenous Leukemia (JCML) Juvenile Myelomonocytic Leukemia (JMML)
Myelodysplastic Syndromes Amyloidosis Chronic Myelomonocytic Leukemia (CMML) Refractory Anemia (RA) Refractory Anemia with Excess Blasts (RAEB) Refractory Anemia with Excess Blasts in Transformation (RAEB-T) Refractory Anemia with Ringed Sideroblasts (RARS)
Stem Cell Disorders Aplastic Anemia (Severe) Congenital Cytopenia Dyskeratosis Congenita Fanconi Anemia Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myeloproliferative Disorders Acute Myelofibrosis Agnogenic Myeloid Metaplasia (Myelofibrosis) Essential Thrombocythemia Polycythemia Vera
Lymphoproliferative Disorders Hodgkin's Disease Non-Hodgkin's Lymphoma Prolymphocytic Leukemia
Phagocyte Disorders Chediak-Higashi Syndrome Chronic Granulomatous Disease Neutrophil Actin Deficiency Reticular Dysgenesis
Liposomal Storage Diseases Adrenoleukodystrophy Gaucher's Disease Hunter's Syndrome (MPS-II) Hurler's Syndrome (MPS-IH) Krabbe Disease Maroteaux-Lamy Syndrome (MPS-VI) Metachromatic Leukodystrophy Morquio Syndrome (MPS-IV) Mucolipidosis II (I-cell Disease) Mucopolysaccharidoses (MPS) Niemann-Pick Disease Sanfilippo Syndrome (MPS-III) Scheie Syndrome (MPS-IS) Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII) Wolman Disease
Histiocytic Disorders Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytosis Histiocytosis-X Langerhans' Cell Histiocytosis
Inherited Erythrocyte Abnormalities Beta Thalassemia Major Blackfan-Diamond Anemia Pure Red Cell Aplasia Sickle Cell Disease
Congenital (Inherited) Immune System Disorders Absence of T & B Cells SCID Absence of T Cells, Normal B Cell SCID Ataxia-Telangiectasia Bare Lymphocyte Syndrome Common Variable Immunodeficiency DiGeorge Syndrome Kostmann Syndrome Leukocyte Adhesion Deficiency Omenn's Syndrome Severe Combined Immunodeficiency (SCID) SCID with Adenosine Deaminase Deficiency Wiskott-Aldrich Syndrome X-Linked Lymphoproliferative Disorder
Other Inherited Disorders Cartilage-Hair Hypoplasia Ceroid Lipofuscinosis Congenital Erythropoietic Porphyria Glanzmann Thrombasthenia Lesch-Nyhan Syndrome Osteopetrosis Tay Sachs Disease
Inherited Platelet Abnormalities Amegakaryocytosis / Congenital Thrombocytopenia
Plasma Cell Disorders Multiple Myeloma Plasma Cell Leukemia Waldenstrom's Macroglobulinemia
Other Malignancies Brain Tumors Ewing Sarcoma Neuroblastoma Ovarian Cancer Renal Cell Carcinoma Small-Cell Lung Cancer Testicular Cancer
Autoimmune Diseases Evan Syndrome Multiple Sclerosis (Experimental) Rheumatoid Arthritis (Experimental) Systemic Lupus Erythematosus (Experimental)
Emerging Clinical Stem Cell Applications
Alzheimer's Disease
Parkinson's Disease
Stroke Doctors are focusing on the ability of the stem cell to differentiate into nerve cells. The approach to treatment would be to regenerate new and healthy nerve cells (tissue) to reduce, alleviate, or eliminate the symptoms or effects of diseases like Alzheimer’s and Parkinson’s and repair damage caused by stroke.
Sanchez-Ramos, J., Song, S., Kamath, S., et al. Expression of neural markers in human umbilical cord blood. Experimental Neurology. 2001;171:109-115. Chen, J., Sanberg, P., Li, Y., et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682-2688.
Diabetes Success using stem cells to regenerate pancreas function and insulin production. May help insulin dependent patients become free of adjunctive therapy (such as insulin injections).
Domenick, M., Ildstad, S. Impact of bone marrow transplantation on type I diabetes. World Journal of Surgery. 2001;25:474-480. Heart Disease Success regenerating heart tissue and blood vessels for treatment of heart disease or traumatic injury to the heart.
Assmus, B., Schachinger, V., Teupe, C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009-3017. Liver Disease Stem cells differentiated into liver cells in mice. Future applications may include repairing liver damage caused by cirrhosis, viral infection, trauma, chemotherapy, or radiation therapy.
Wang X., Ge S., McNamara G., et al. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood. 2003;101(10):4201-4208. Lupus Following stem cell transplantation patients with severe lupus have been able to regenerate blood cells that are completely free of the disease.
Brunner, M., Greinix, H., Redlich, K., et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment. Arthritis & Rheumatism. 2002;46(6):1580-1584. Multiple Sclerosis Stem cell transplantation has stopped and even reversed disease progression for some patients with multiple sclerosis.
Kozak, T. Hematopoietic stem cell transplantation in the treatment of autoimmune diseases. The Middle European Journal of Medicine. 2002;114(1-2; 7-13) Muscular Dystrophy Stem cells have been proven to fuse into skeletal muscle cells in patients with muscular dystrophy. Transplantation may help slow or stop the progression of muscle wasting.
Gussoni, E., Bennett, R., Muskiewicz, K., et al. Long term persistence of donor nuclei in a duchenne muscular dystrophy patient receiving bone marrow transplantation, The Journal of Clinical Investigation, 2002;110(6):807-814. Spinal Cord Injury In animal studies cord blood stem cells are beneficial in helping to reverse paralysis caused by spinal cord injury. Cord blood-derived stem cells were shown to migrate to and participate in the healing of neurological defects caused by traumatic assault.
Saporta, S., Kim, J., Willing, A., et al. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. Journal of Hematotherapy & Stem Cell Research. 2003; 12:271-278.
|